155 related articles for article (PubMed ID: 30401637)
1. Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α.
Xu A; Wang B; Fu J; Qin W; Yu T; Yang Z; Lu Q; Chen J; Chen Y; Wang H
Cancer Lett; 2019 Feb; 442():40-52. PubMed ID: 30401637
[TBL] [Abstract][Full Text] [Related]
2. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
3. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of dieckol on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Sadeeshkumar V; Duraikannu A; Ravichandran S; Fredrick WS; Sivaperumal R; Kodisundaram P
Biomed Pharmacother; 2016 Dec; 84():1810-1819. PubMed ID: 27825803
[TBL] [Abstract][Full Text] [Related]
5. Binge ethanol-induced HDAC3 down-regulates Cpt1α expression leading to hepatic steatosis and injury.
Kirpich I; Zhang J; Gobejishvili L; Kharebava G; Barker D; Ghare S; Joshi-Barve S; McClain CJ; Barve S
Alcohol Clin Exp Res; 2013 Nov; 37(11):1920-9. PubMed ID: 23905631
[TBL] [Abstract][Full Text] [Related]
6. Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis.
Pok S; Barn VA; Wong HJ; Blackburn AC; Board P; Farrell GC; Teoh NC
J Gastroenterol Hepatol; 2016 Jun; 31(6):1210-9. PubMed ID: 26574916
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
[TBL] [Abstract][Full Text] [Related]
8. Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult.
Yao Y; Sun S; Wang J; Fei F; Dong Z; Ke AW; He R; Wang L; Zhang L; Ji MB; Li Q; Yu M; Shi GM; Fan J; Gong Z; Wang X
Cancer Res; 2018 Oct; 78(19):5548-5560. PubMed ID: 30065049
[TBL] [Abstract][Full Text] [Related]
9. Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice.
Ye H; Zhang C; Wang BJ; Tan XH; Zhang WP; Teng Y; Yang X
Oncogene; 2014 Oct; 33(43):5133-8. PubMed ID: 24213574
[TBL] [Abstract][Full Text] [Related]
10. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
11. SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice.
Li L; Wang C; Calvisi DF; Evert M; Pilo MG; Jiang L; Yuneva M; Chen X
PLoS One; 2013; 8(9):e75104. PubMed ID: 24069385
[TBL] [Abstract][Full Text] [Related]
12. Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
Han B; Shin HJ; Bak IS; Bak Y; Jeong YL; Kwon T; Park YH; Sun HN; Kim CH; Yu DY
Oncotarget; 2016 Oct; 7(42):68044-68056. PubMed ID: 27517622
[TBL] [Abstract][Full Text] [Related]
13. TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice.
Jiang S; Minter LC; Stratton SA; Yang P; Abbas HA; Akdemir ZC; Pant V; Post S; Gagea M; Lee RG; Lozano G; Barton MC
J Hepatol; 2015 Feb; 62(2):371-9. PubMed ID: 25281858
[TBL] [Abstract][Full Text] [Related]
14. Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis.
Ridruejo E; Romero-Caími G; Obregón MJ; Kleiman de Pisarev D; Alvarez L
Ann Hepatol; 2018; 17(3):490-500. PubMed ID: 29735800
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
[TBL] [Abstract][Full Text] [Related]
16. E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
González-Romero F; Mestre D; Aurrekoetxea I; O'Rourke CJ; Andersen JB; Woodhoo A; Tamayo-Caro M; Varela-Rey M; Palomo-Irigoyen M; Gómez-Santos B; de Urturi DS; Núñez-García M; García-Rodríguez JL; Fernández-Ares L; Buqué X; Iglesias-Ara A; Bernales I; De Juan VG; Delgado TC; Goikoetxea-Usandizaga N; Lee R; Bhanot S; Delgado I; Perugorria MJ; Errazti G; Mosteiro L; Gaztambide S; Martinez de la Piscina I; Iruzubieta P; Crespo J; Banales JM; Martínez-Chantar ML; Castaño L; Zubiaga AM; Aspichueta P
Cancer Res; 2021 Jun; 81(11):2874-2887. PubMed ID: 33771899
[TBL] [Abstract][Full Text] [Related]
17. Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice.
Gavito AL; Bautista D; Suarez J; Badran S; Arco R; Pavón FJ; Serrano A; Rivera P; Decara J; Cuesta AL; Rodríguez-de-Fonseca F; Baixeras E
PLoS One; 2016; 11(6):e0157956. PubMed ID: 27333268
[TBL] [Abstract][Full Text] [Related]
18. Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation.
Mo Y; Wu Y; Li X; Rao H; Tian X; Wu D; Qiu Z; Zheng G; Hu J
Eur J Pharmacol; 2020 Jan; 867():172788. PubMed ID: 31712058
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models.
Chew TW; Liu XJ; Liu L; Spitsbergen JM; Gong Z; Low BC
Oncogene; 2014 May; 33(21):2717-27. PubMed ID: 23812423
[TBL] [Abstract][Full Text] [Related]
20. The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats.
Galant LW; de Mattos AA; Menti E; Valiatti FB; de Mattos AZ; Porawski M; Hartmann A; Rhoden CR
Ann Hepatol; 2013; 12(3):425-33. PubMed ID: 23619259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
